Gulf Coast Dermatopathology Laboratory, Dermatology Associates of Tampa Bay, Tampa, FL.
Surgical Dermatology Group, Birmingham, AL.
Mayo Clin Proc. 2021 Apr;96(4):989-1005. doi: 10.1016/j.mayocp.2021.01.009. Epub 2021 Jan 21.
Pernio or chilblains is characterized by erythema and swelling at acral sites (eg, toes and fingers), typically triggered by cold exposure. Clinical and histopathologic features of pernio are well described, but the pathogenesis is not entirely understood; vasospasm and a type I interferon (IFN-I) immune response are likely involved. During the coronavirus disease 2019 (COVID-19) pandemic, dermatologists have observed an increase in pernio-like acral eruptions. Direct causality of pernio due to COVID-19 has not been established in many cases because of inconsistent testing methods (often negative results) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, a form of COVID-19‒associated pernio (also called COVID toes) is probable because of increased occurrence, frequently in young patients with no cold exposure or a history of pernio, and reports of skin biopsies with positive SARS-CoV-2 immunohistochemistry. PubMed was searched between January 1, 2020, and December 31, 2020 for publications using the following keywords: pernio, chilblain, and acral COVID-19. On the basis of our review of the published literature, we speculate that several unifying cutaneous and systemic mechanisms may explain COVID-19‒associated pernio: (1) SARS-CoV-2 cell infection occurs through the cellular receptor angiotensin-converting enzyme 2 mediated by transmembrane protease serine 2, subsequently affecting the renin-angiotensin-aldosterone system with an increase in the vasoconstricting, pro-inflammatory, and prothrombotic angiotensin II pathway. (2) Severe acute respiratory syndrome coronavirus 2 cell infection triggers an immune response with robust IFN-I release in patients predisposed to COVID-19‒associated pernio. (3) Age and sex discrepancies correlated with COVID-19 severity and manifestations, including pernio as a sign of mild disease, are likely explained by age-related immune and vascular differences influenced by sex hormones and genetics, which affect susceptibility to viral cellular infection, the renin-angiotensin-aldosterone system balance, and the IFN-I response.
冻疮或寒冷性多形红斑的特征为肢端部位(如脚趾和手指)出现红斑和肿胀,通常由寒冷暴露所诱发。冻疮的临床和组织病理学特征已有详细描述,但发病机制尚未完全明确;血管痉挛和 I 型干扰素(IFN-I)免疫反应可能与之相关。在 2019 冠状病毒病(COVID-19)大流行期间,皮肤科医生观察到肢端类似冻疮样疹的出现有所增加。由于严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的检测方法不一致(通常为阴性结果),许多情况下并未确立 COVID-19 导致的冻疮的直接因果关系。然而,由于 COVID-19 相关冻疮(也称 COVID 脚趾)的发生增加,且通常见于无寒冷暴露或冻疮病史的年轻患者,且有 SARS-CoV-2 免疫组织化学阳性的皮肤活检报告,因此 COVID-19 相关冻疮很可能存在。于 2020 年 1 月 1 日至 12 月 31 日在 PubMed 上使用以下关键词搜索发表的文献:冻疮、寒冷性多形红斑和肢端 COVID-19。基于我们对已发表文献的回顾,我们推测几种统一的皮肤和全身机制可能解释 COVID-19 相关冻疮:(1)SARS-CoV-2 通过跨膜蛋白酶丝氨酸 2 介导的细胞受体血管紧张素转化酶 2 发生细胞感染,随后影响肾素-血管紧张素-醛固酮系统,血管紧张素 II 途径的血管收缩、促炎和促血栓形成增加。(2)SARS-CoV-2 细胞感染会引发免疫反应,使易患 COVID-19 相关冻疮的患者大量释放 IFN-I。(3)与 COVID-19 严重程度和表现相关的年龄和性别差异,包括作为轻症表现的冻疮,可能归因于年龄相关的免疫和血管差异,这些差异受性激素和遗传因素影响,从而影响对病毒细胞感染的易感性、肾素-血管紧张素-醛固酮系统平衡和 IFN-I 反应。